2893 A - Efficacy and Safety of Aztreonam-Avibactam for the Treatment of Serious Infections Due to Gram-Negative Bacteria, Including Metallo-β-Lactamase-Producing Pathogens: Phase 3 REVISIT Study

Presenting Author(s)

• 

  Yehuda Carmeli, MD

  Professor of Medicine, Head of the Israeli National Center for Antibiotic Resistance, Chief of the Division of Epidemiology
  Israel Ministry of Health
  Tel Aviv, Tel Aviv, Israel

  Slides

Co-Author(s)

• JC

  Jose-Miguel Cisneros, MD, PhD

  Virgen del Rocío University Hospital-IBiS
  Seville, Andalucia, Spain
• MP

  Mical Paul, MD

  Rambam Health Care Campus
  Haifa, Hefa, Israel
• GD

  Georgios L. Daikos, PhD

  Professor
  laiko General Hospital
  Athens, Attiki, Greece
• MW

  Minggui Wang, MD

  Professor
  Institute of Antibiotics, Huashan Hospital, Fudan University
  Shanghai, Shanghai, China (People's Republic)
• JT

  Julian Torre Cisneros, Md, Ph.D

  Head
  Hospital Universitario Reina Sofia
  Córdoba, Andalucia, Spain
• GS

  George Singer, MD

  Harbor-UCLA Medical Center
  Torrance, California, United States
• IT

  Ivan Titov, MD, PhD, ScD

  Ivano-Frankivsk National Medical University
  Ivano-Frankivsk, Ivano-Frankivs'ka Oblast', Ukraine
• IG

  Illia Gumenchuk, MD

  Communal Non-profit Enterprise Vinnytsia Regional Clinical Hospital Named after M.I.Pyrogov Vinnytsia Regional Council
  Vinnytsia, Vinnyts'ka Oblast', Ukraine
• YZ

  Yongjie Zhao, MD

  Tianjin Union Medical Center
  Tianjin, Hebei, China
• RJ

  Rosa-María Jiménez Rodríguez, MD, PhD

  Virgen del Rocío University Hospital-IBiS
  Seville, Andalucia, Spain
• LL

  Lu Liang, MD

  Baotou Central Hospital
  Baotou, Nei Mongol, China
• GC

  Gang Chen, n/a

  The First Hospital of Kunming
  Kunming, Yunnan, China
• OP

  Oleksandr Pyptiuk, MD

  Ivano-Frankivsk National Medical University
  Ivano-Frankivsk, Ivano-Frankivs'ka Oblast', Ukraine
• FA

  Firdevs Aksoy, Ass. Prof. MD

  Prof. MD
  Karadeniz Technical Univ.
  Trabzon, Trabzon, Turkey
• HR

  Halley Rogers, MPH

  Pfizer Clinical Development & Operations
  New York, New York, United States
• MW

  Michele Wible, MS

  Pfizer WW Research & Development
  Collegeville, Pennsylvania, United States
• FA

  Francis Arhin, PhD

  Director, Developmental Microbiology
  Pfizer, Inc.
  Kirkland, Manitoba, Canada
• AL

  Alison Luckey, MD

  Global Antibiotic R&D Partnership
  Geneva, Geneve, Switzerland
• JL

  Joanne Leaney, PhD

  Pfizer WW Research & Development
  Sandwich, England, United Kingdom
• RP

  Rienk Pypstra, MD, MBA

  Pfizer Inc
  New York, New York, United States
• JC

  Joseph Chow, MD

  Pfizer Global Product Development
  Collegeville, Pennsylvania, United States